The Veterinary33 debates Veterinary News

26 June 2026

Idiopathic Hypercalcemia in Cats

New university findings highlight potential implications for dogs, cancer, and veterinary practice.

If your cat is eligible for the study, you will need to: Present your cat to Michigan State University for examination and blood tests at baseline and then at 6 and 24 weeks.

Idiopathic Hypercalcemia in Cats | College of Veterinary Medicine at MSU Support the College of Veterinary Medicine Search Tool Clinical Trials Select Chronic Kidney Disease in Cats Direct Comparison of CHOP and LOPP Chemotherapy and Genomic Analysis for Naïve T Cell Lymphoma in Client-owned Dogs FAQs with Dr.

Investigators: Professor Caroline Mansfield and Dr.

Haley Momany Background: Calcium is one of the most tightly regulated salts (electrolytes) in the body.

High calcium concentrations in the blood, or hypercalcemia, can occur due to several reasons including infection, cancer and renal dysfunction.

In cats, the most common cause is unknown, and this phenomenon is called idiopathic hypercalcemia (IHC).

If hypercalcemia persists, it can cause damage to the kidneys and changes in thirst, urination, and appetite.

Therefore, as veterinarians, we seek to identify an underlying cause as quickly as possible.

If we cannot find one and make a diagnosis of IHC, we struggle to figure out why patients have this condition, or to manage it appropriately.

Project description: In this project, we will evaluate if the gut (GI) microbiome plays a role in the development of this condition.

We will also undertake a clinical trial to determine if probiotic may benefit in a blinded manner.

The report adds to ongoing university-led research relevant to veterinary medicine, animal health, and clinical decision-making.

Source university website: Michigan State University College of Veterinary Medicine

https://cvm.msu.edu/hospital/veterinarians/clinical-trials/idiopathic-hypercalcemia-in-cats

Event Website

https://www.avma.org/events

Like0

Dislike1

List
Add

Please enter a comment

Name *

Email address *

Comment *

* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.

I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies

Dislike1

News of interest

A Systematic Review and Meta-Analysis on the Global Seroprevalence of Porcine Reproductive and Respiratory Virus (PRRSV) in Pigs and Wild Boars: A Widespread and Impactful Swine Virus.

EXPRESS: Azotaemia and outcomes in male cats with initial and recurrent urethral obstruction: a multicentre retrospective study of 601 cats (2020-2024).

Hantavirus Outbreak Raises Questions—Here’s How We Can Protect Ourselves

Soluble triggering receptor expressed on myeloid cells-1 as a predictive biomarker in sepsis: insights into cut-offs, mortality risk, and treatment guidance-secondary analysis of the Next GeneSiS-Trial.

EVENTS

Edrapublishing

About Us Authors Contact Us Legal Notes Privacy Search

Top

Idiopathic Hypercalcemia in Cats

New university findings highlight potential implications for dogs, cancer, and veterinary practice.

Comments

List

Add

Tag

Related Articles

25 June 2026
Strengthening

Strengthening

24 June 2026
Use of a Novel Imaging System as a Non-Invasive Diagnostic Tool for Evaluating Feline Iris Melanocytic Tumors

Use of a Novel Imaging System as a Non-Invasive Diagnostic Tool for Evaluating Feline Iris Melanocytic Tumors

23 June 2026
Enhancing Capacity for Infectious Disease Research

Enhancing Capacity for Infectious Disease Research

22 June 2026
Pilot Study for a New Quasiorganelle Therapy in Dogs with Histiocytic Sarcoma

Pilot Study for a New Quasiorganelle Therapy in Dogs with Histiocytic Sarcoma

19 June 2026
House Officer Reflections June 17, 2026

House Officer Reflections June 17, 2026

More news

Unified Information Devices, Inc.

Effectiveness and long-term safety of repeated oral administrations of molidustat in the management of anemia associated with chronic kidney disease in cats.

The polysaccharide Pullulan improves the initial steps of allergen-specific immunotherapy in dogs.

Real-world use of and clinical outcomes with dacomitinib as first-line therapy in Asian patients with EGFR mutation-positive locally advanced or metastatic non-small cell lung cancer: Final analysis of the ARIA study.